Delivery Order SPE2DB22D3016-SPE2DB25FBEN2
- Not listed
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $5,072.07. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor based on standard federal procurement practices. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the order is scheduled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for Terbinafine HCL 250 mg tablets (30-count) with a ceiling value of $1,015.23. This firm fixed-price delivery order, which is not set-aside, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,165.31 on August 8, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,801.47 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30. This firm fixed price contract, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set aside for small business or other designated categories and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract value of $2,205.41. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract ceiling value of $7,834.63. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $42,212 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 28, 2025. The contract was executed on July 25, 2025, with performance to be conducted at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,108.47 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEN2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 with a ceiling value of $1,501.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/11/25 |